MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Efaproxiral

CAS No. : 131179-95-8

MCE 国际站：Efaproxiral

产品活性：Efaproxiral (RSR13) 是一种血红蛋白 (Hb) 合成变构调节剂, 能降低血红蛋白氧 (O2) 的结合亲和力，增强放射处理中缺氧肿瘤的氧合作用。

研究领域：Immunology/Inflammation | NF-κB | Metabolic Enzyme/Protease

作用靶点：Reactive Oxygen Species

In Vitro: Efaproxiral binds to only one pair of symmetry-related sites in the Hb central water cavity.
Efaproxiral readily crosses the red cell membrane in the presence of serum albumin solutions.
Efaproxiral is not inhibited from entering erythrocytes in the presence of an anion-channel blocking agent (DIDS).

In Vivo: Efaproxiral (150 mg/kg, i.p.) increase tumor oxygenation，and increase the tumor growth inhibition of radiotherapy over 5 days of treatment.
Efaproxiral reduces hemoglobin-oxygen binding affinity, which facilitates oxygen release from hemoglobin into surrounding tissues and potentially increases the pO(2) of the tumors

相关产品：Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | NF-κB Signaling Compound Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Antioxidants Compound Library | Oxygen Sensing Compound Library | Ferroptosis Compound Library | Anti-COVID-19 Compound Library | Pyroptosis Compound Library | FDA Approved & Pharmacopeial Drug Library | Acetylcysteine | H2DCFDA | Quercetin | Mitoquinone mesylate | (-)-Epigallocatechin Gallate | L-Ascorbic acid | Diphenyleneiodonium chloride | Mito-TEMPO | GSK2795039 | Trolox | L-Glutathione reduced | Dimethyl fumarate | Berberine chloride | Zinc Protoporphyrin | Sodium dichloroacetate | Lycopene | 2-Methoxyestradiol | TPEN | Urolithin A | α-Vitamin E | Tempol | Piperlongumine | Coenzyme Q10 | Asiaticoside | N-Acetylcysteine amide | D-α-Hydroxyglutaric acid disodium | Rhein | Elesclomol | Ellagic acid | Nobiletin

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。